Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/15/19
End: 09/15/20
Due: 09/15/21
Phase: N/A
Priority: Normal
Start: 03/31/12
End: 11/30/16
Due: 11/30/17
Phase: N/A
Priority: Normal
Start: 02/28/19
End: 03/31/22
Due: 03/31/23
Phase: N/A
Priority: Normal
Start: 10/31/15
End: 09/30/16
Due: 09/30/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Identifying Novel Biomarkers in Early Rheumatology Patients | NCT03843658 | Arthritis Northwest PLLC | user2@example.com | None | 2019-03-15 | 2020-09-15 | 2021-09-15 | - | - | 2025-07-14 |
| Real-world Clinical Efficacy of Abatacept in the T3 Data Registry | NCT01555879 | Arthritis Northwest PLLC | user2@example.com | None | 2012-03-31 | 2016-11-30 | 2017-11-30 | - | - | 2025-07-14 |
| Electronic and Lab Pre-screening of New Rheumatology Patients With Rheumatoid Arthritis | NCT03843619 | Arthritis Northwest PLLC | user2@example.com | None | 2019-02-28 | 2022-03-31 | 2023-03-31 | - | - | 2025-07-14 |
| Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease | NCT02742337 | Arthritis Northwest PLLC | user2@example.com | None | 2015-10-31 | 2016-09-30 | 2017-09-30 | - | - | 2025-07-14 |